Muc16

Top News

• Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

  PR Newswire 2026-10-01, 13:14

  MUC16 Expression Remained High and Stable Following Standard-of-Care Therapies, Supporting Its Potential...